These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37124223)

  • 21. Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments.
    Wang Z; Chen G; Chen L; Liu X; Fu W; Zhang Y; Li C; Liang G; Cai Y
    Mol Biosyst; 2015 Jul; 11(7):1933-8. PubMed ID: 25923908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential anticancer effect of prostratin through SIK3 inhibition.
    Alotaibi D; Amara S; Johnson TL; Tiriveedhi V
    Oncol Lett; 2018 Mar; 15(3):3252-3258. PubMed ID: 29435066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach.
    Anbarasu K; Jayanthi S
    3 Biotech; 2018 May; 8(5):228. PubMed ID: 29719770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
    Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.
    Ponnusamy L; Kothandan G; Manoharan R
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165897. PubMed ID: 32682817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-silico and in-vitro investigation of STAT3-PIM1 heterodimeric complex: Its mechanism and inhibition by curcumin for cancer therapeutics.
    Mahata S; Behera SK; Kumar S; Sahoo PK; Sarkar S; Fazil MHUT; Nasare VD
    Int J Biol Macromol; 2022 May; 208():356-366. PubMed ID: 35346675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx.
    Babaer D; Amara S; Ivy M; Zhao Y; Lammers PE; Titze JM; Tiriveedhi V
    Oncotarget; 2018 May; 9(38):25193-25205. PubMed ID: 29861863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.
    Sorrentino A; Menevse AN; Michels T; Volpin V; Durst FC; Sax J; Xydia M; Hussein A; Stamova S; Spoerl S; Heuschneider N; Muehlbauer J; Jeltsch KM; Rathinasamy A; Werner-Klein M; Breinig M; Mikietyn D; Kohler C; Poschke I; Purr S; Reidell O; Martins Freire C; Offringa R; Gebhard C; Spang R; Rehli M; Boutros M; Schmidl C; Khandelwal N; Beckhove P
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35606086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
    Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
    Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin binds in silico to anti-cancer drug target enzyme MMP-3 (human stromelysin-1) with affinity comparable to two known inhibitors of the enzyme.
    Jerah A; Hobani Y; Kumar BV; Bidwai A
    Bioinformation; 2015; 11(8):387-92. PubMed ID: 26420919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
    Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
    J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.
    Itoh Y; Sanosaka M; Fuchino H; Yahara Y; Kumagai A; Takemoto D; Kagawa M; Doi J; Ohta M; Tsumaki N; Kawahara N; Takemori H
    J Biol Chem; 2015 Jul; 290(29):17879-17893. PubMed ID: 26048985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
    Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
    Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway.
    Jia T; Zhang L; Duan Y; Zhang M; Wang G; Zhang J; Zhao Z
    Cancer Cell Int; 2014; 14(1):126. PubMed ID: 25530715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila.
    Choi S; Lim DS; Chung J
    PLoS Genet; 2015 May; 11(5):e1005263. PubMed ID: 25996931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
    Zhu J; Wu Y; Xu L; Jin J
    Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
    Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Mutant
    Iwasaki K; Fujiyama T; Nakata S; Park M; Miyoshi C; Hotta-Hirashima N; Ikkyu A; Kakizaki M; Sugiyama F; Mizuno S; Abe M; Sakimura K; Takahashi S; Funato H; Yanagisawa M
    J Neurosci; 2021 Mar; 41(12):2733-2746. PubMed ID: 33558433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylpyrazalopyrimidines as Tyrosine Kinase Inhibitors: Synthesis, Antiproliferative Activity, and Molecular Simulations.
    Chhikara BS; Ashraf S; Mozaffari S; St Jeans N; Mandal D; Tiwari RK; Ul-Haq Z; Parang K
    Molecules; 2020 May; 25(9):. PubMed ID: 32370213
    [No Abstract]   [Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors.
    Wang J; Zhang X; Yan J; Li W; Jiang Q; Wang X; Zhao D; Cheng M
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126683. PubMed ID: 31627991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.